Q32 Bio Inc. - Common Stock QTTB 深 沪
等待开盘 09-20 09:30:00 美东时间
47.17
+0.770
+1.66%
华盛通- 最 高50.125
- 今 开47.22
- 成交量 9.35万股
- 最 低 46.3511
- 昨 收 46.40
- 总市值 5.71亿
- 52周最高 53.79
- 市盈率 静 --
- 换手率 0.77%
- 52周最低 8.244
- 委 比 8.68%
- 总股本 1210.00万
- 历史最高 572.40
- 量 比 0.69
- 振 幅 8.13%
- 历史最低 8.244
- 每 手 1
- 风险率 9.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Q32 Bio GAAP EPS of -$1.42
Q32 Bio press release (NASDAQ:QTTB): Q2 GAAP EPS of -$1.42. Cash, cash equivalents, and short-term investments of $107.6 million as of June 30, 2024, More on Q32 Bio Russell 2000 rise: Top 5 best, wo...
08-08 20:50
Q32 Bio Advances in Atopic Dermatitis Treatment Trial
Q32 Bio (QTTB) has issued an announcement. Q32 Bio Inc. has successfully comple...
07-09 19:28
Q32 Bio Joins Russell 3000® Index
WALTHAM, Mass., July 1, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune hom...
07-01 18:59
美股牛股 | 英飞朗隔夜涨幅15.8%，诺基亚计划收购Infinera，提升光网络市场竞争力
英飞朗: 隔夜涨幅15.8%，诺基亚计划收购Infinera，提升光网络市场竞争力
06-29 09:52
Market-Moving News for June 17th
BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106 ZYME: 13% | Zymeworks shares are trading higher after the FDA cleared the company's Investigational New Drug application for
06-17 20:40
Q32 Bio (QTTB) Gets a Buy from Oppenheimer
In a report released today, Jay Olson from Oppenheimer maintained a Buy rating ...
05-13 19:55
Q32 Bio(QTTB.US)：2024年Q1财报实现营收0美元，前值为294.7万美元，预期值为17万美元；每股收益为-6.33美元，前值为-19.84美元，预期值为-2.32美元。
Q32 Bio(QTTB.US)：2024年Q1财报实现营收0美元，前值为294.7万美元，预期值为17万美元；每股收益为-6.33美元，前值为-19.84美元...
05-09 21:41
Q32 Bio Reports Q1 2024 GAAP EPS Of $(6.33)
Cash, cash equivalents, and short-term investments were $135.3 million as of March 31, 2024, which are expected to provide financial runway through four Phase 2 clinical milestones and into mid-2026.
05-09 19:41
Veru, Theravance Biopharma, Adial Pharmaceuticals among healthcare movers
Gainers: Allarity Therapeutics (ALLR) +36%. Q32 Bio QTTB +15%. Entera Bio (ENTX) +16%. Mobile-health Network Solutions (MNDR) +13%. Theravance Biopharma (TBPH) +11%. Losers: Veru (VERU) -12%. Adial ...
04-12 22:00
Q32 Bio(QTTB.US)获奥本海默首次覆盖，给予优于大市评级, 目标价50.00美元。
Q32 Bio(QTTB.US)获奥本海默首次覆盖，给予优于大市评级, 目标价50.00美元。
04-11 17:51
